In contrast, PIK3CA mutations and copy number gains of components of FGFR signaling pathway have been described as oncogenic drivers of squamous cell carcinoma of different origin including lung, head and neck, and stomach [16]. Here, PIK3CA is linked to squamous cell carcinoma.